First High-Quality Study to Explore A Carnivore-Style Diet in Managing Metabolic Health, WhichAffects Millions of AmericansOver one-third of U.S. adults – or 115.2 million Americans – are prediabetic, ...

The agency pointed to what it sees as a contradictory signal within uniQure's own dataset. Sham-controlled data from a small cohort of U.S. patients showed no treatment effect at 12 months, a finding ...

Pivotal study shows no clear benefit for the common endoscopic procedure in this patient group. Experts say the new data ...

Interest in GLP-1s for addiction has grown in the past decade, as some people prescribed them for diabetes or weight loss ...

An international, randomized, double-blind, placebo-controlled Phase III study—the largest of its kind for mpox—found that tecovirimat did not improve clinical outcomes for adults with clade II mpox ...

A class of medications best known for treating diabetes and obesity may also reduce the risk of addiction—and help people who already have one, a new study shows.

Orforglipron, a novel oral nonpeptide GLP-1 receptor agonist (RA), led to a greater reduction in A1c and more significant weight loss compared to oral semaglutide in patients with type 2 diabetes (T2D ...

In a strikingly blunt briefing, a senior FDA official accused uniQure of pushing “distorted” data to mask a “failed” therapy ...

L-theanine, an amino acid found in tea, is touted for relaxation and focus, but more research is needed to know if taking ...

A class of medications best known for treating diabetes and obesity may also reduce the risk of addiction – and help people ...

Drinks high in potassium include fruit juices, such as prune, pomegranate, tomato, orange, and coconut. Other drinks include ...

The MarketWatch News Department was not involved in the creation of this content.-- Cebranopadol is an investigational first-of-its kind dual NOP/MOP receptor (NMR) agonist which ...